Centrus Energy: The Real Risk Behind SWU Pricing
Centrus Energy (LEU) is up 25% YTD, driven by its unique position as the only U.S.-owned HALEU enrichment provider. LEU trades at a 70x P/E, reflecting strategic scarcity and national security value, but faces margin compression from a sales mix shift and legacy contracts. Key risks include multiple compression, dilution from a $1B ATM program, and a $2.3B contingent backlog dependent on financing and capacity expansion.
Is It Too Early To Buy Nuclear Stocks?
Nuclear stocks were some of the biggest winners over the past year as investors are starting to notice their role in the AI bottleneck.
ETFs Primed to Benefit From America's $2.7 Billion Nuclear Push
The DOE's $2.7 billion push to build U.S. uranium enrichment capacity could fuel a nuclear revival - and make ETFs like URA compelling plays.
Why The Recent Drop In Centrus Is A Gift For Investors
I'm upgrading Centrus Energy (LEU) to Buy, which is reflective of the improved valuation and strategic progress in HALEU enrichment. LEU's unique position as the only U.S. HALEU producer aligns with surging demand from next-generation nuclear reactors. A $900 million DOE grant and multi-billion dollar expansion in Piketon, Ohio, strengthen LEU's growth trajectory.
Centrus Energy: A Tactical Buy After Meta's Atomic Deal
Centrus Energy is a tactical buy, reflecting its strategic role in the nuclear fuel supply chain despite high valuation and volatility. LEU's uranium enrichment capacity is a critical bottleneck for next-generation nuclear reactors, positioning it as a strategic asset amid AI-driven energy demand. Traditional valuation metrics are less relevant; the market is pricing in supply chain security and future optionality rather than near-term earnings.
LEU Enrichment Scale-Up: A Win for U.S. Energy Independence?
Centrus Energy begins industrial-scale centrifuge manufacturing in Ohio, a key step toward restoring U.S.-owned uranium enrichment after a decade-long gap.
LEU vs. NXE: Which Uranium Stock is the Smarter Bet Now?
Centrus Energy's HALEU advantage, $3.9B backlog and Ohio expansion are tested as investors weigh which uranium stock wins amid rebounding prices.
Centrus Energy Soars 297.1% YTD: Is There More Upside Ahead?
LEU surges as Q3 revenues jump, backlog swells to $3.9B and major enrichment expansion plans take shape.
Centrus Energy's Q3 Revenues Up on Uranium Sales: More Upside Ahead?
LEU's Q3 revenues jump 30% on renewed uranium sales, while Technical Solutions posted strong growth from its HALEU contract.
3 Nuclear Energy Stocks That Show Great Potential
Artificial intelligence has driven demand for multiple industries while creating many stock opportunities.
LEU vs. UEC: Which Uranium Stock Offers Better Upside Now?
Centrus Energy gains momentum with rising uranium demand, HALEU leadership and major expansion plans fueling its long-term growth outlook.
Centrus Energy: Key Enabler Of U.S. Advanced Nuclear Technology
Centrus Energy is benefiting from its critical point in the U.S. nuclear fuel cycle, enabling the next-generation reactor development. LEU could benefit substantially from its centrifuge cascade technology due to the growing need for nuclear power. The SWU potential could reach up to 70 million once SMRs and advanced reactors start deploying, implying the company could grow at a 20% rate going forward.
